Advisory Research’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,230
| Closed | -$980K | – | 428 |
|
|
2021
Q1 | $980K | Sell |
7,230
-248
| -3% | -$33.6K | 0.07% | 209 |
|
|
2020
Q4 | $957K | Sell |
7,478
-2,017
| -21% | -$258K | 0.07% | 198 |
|
|
2020
Q3 | $1.07M | Sell |
9,495
-805
| -8% | -$90.5K | 0.1% | 168 |
|
|
2020
Q2 | $981K | Buy |
10,300
+1,941
| +23% | +$185K | 0.09% | 171 |
|
|
2020
Q1 | $751K | Buy |
+8,359
| New | +$751K | 0.05% | 153 |
|
|
2019
Q1 | – | Sell |
-17,988
| Closed | -$783K | – | 390 |
|
|
2018
Q4 | $783K | Sell |
17,988
-16,772
| -48% | -$730K | 0.02% | 259 |
|
|
2018
Q3 | $1.99M | Buy |
34,760
+10,494
| +43% | +$600K | 0.03% | 200 |
|
|
2018
Q2 | $1.18M | Buy |
+24,266
| New | +$1.18M | 0.02% | 259 |
|
|
2017
Q1 | – | Sell |
-30,481
| Closed | -$778K | – | 428 |
|
|
2016
Q4 | $778K | Buy |
+30,481
| New | +$778K | 0.01% | 298 |
|